Keywords: fda, priority, review, topotarget, totect, danish, drugmaker

FDA priority review for TopoTarget's Totect

Article | 17 April 2006

Print This

Danish drugmaker TopoTarget says that the US Food and Drug Administration has granted priority review status to its marketing approval ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in